Charles River Laboratories
About: Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Employees: 20,100
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.03% less ownership
Funds ownership: 103.58% [Q4 2024] → 103.55% (-0.03%) [Q1 2025]
12% less funds holding
Funds holding: 628 [Q4 2024] → 552 (-76) [Q1 2025]
16% less call options, than puts
Call options by funds: $106M | Put options by funds: $125M
20% less capital invested
Capital invested by funds: $10B [Q4 2024] → $7.96B (-$2.04B) [Q1 2025]
22% less repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 237
47% less first-time investments, than exits
New positions opened: 70 | Existing positions closed: 133
50% less funds holding in top 10
Funds holding in top 10: 4 [Q4 2024] → 2 (-2) [Q1 2025]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Redburn Atlantic Jamie Clark | 22%upside $182 | Buy Upgraded | 23 May 2025 |
Barclays Luke Sergott | 4%upside $155 | Equal-Weight Maintained | 8 May 2025 |
Baird Eric Coldwell | 6%downside $140 | Neutral Maintained | 8 May 2025 |
Mizuho Ann Hynes | 4%upside $155 | Neutral Maintained | 9 Apr 2025 |
Goldman Sachs Matthew Sykes | 14%upside $170 | Neutral Downgraded | 21 Mar 2025 |
Financial journalist opinion
Based on 6 articles about CRL published over the past 30 days
